Stocks · Health care · Pharmaceutical Preparations

Kura Oncology, Inc.

KURA Clue Score49

United States Fiscal year ends December CIK 0001422143 Results filed 12 Aug 2026

Add to watchlist

By person

9 insiders · 44 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Troy Edward Wilson

President and CEO

$2.35M (2)

—

+$2.35M

914,650

1.03%

$9.83M

+226.5%

Mollie Leoni

Chief Medical Officer

—

$1.52M (8) scheduled

−$1.52M

141,095

0.1586%

$1.52M

+200.4%

Teresa Brophy Bair

Chief Legal Officer

—

$700.69K (7) scheduled

−$700.69K

187,002

0.2102%

$2.01M

+156.9%

Brian T. Powl

Chief Commercial Officer

—

$663.42K (9)

−$663.42K

136,819

0.1538%

$1.47M

+772.7%

Francis Burrows

Chief Scientific Officer

—

$467.54K (3) scheduled

−$467.54K

42,327

0.0476%

$454.96K

+67.6%

Kathleen Ford

Chief Operating Officer

—

$224.90K (5) scheduled

−$224.90K

142,986

0.1607%

$1.54M

+14.1%

Thomas James Doyle

SVP, Finance & Accounting

—

$159.52K (7)

−$159.52K

142,928

0.1607%

$1.54M

+159.8%

Faheem Hasnain

Director

—

$109.76K (1) scheduled

−$109.76K

23,983

0.0270%

$257.79K

0.0%

Thomas Malley

Director

—

10,000

0.0112%

$107.49K

—

Kura Oncology, Inc.

What the insiders did Net buying

By person